Opioid Use Disorder Stigma and Support for Harm Reduction in Rural Counties

References

• Agency for Healthcare Research and Quality (AHRQ). (2018) Healthcare Cost and Utilization Project (HCUP). Nationwide Emergency Department Sample (NEDS), 2011–2018. Retrieved March 3, 2022 from https://www.hcup-us.ahrq.gov/faststats/OpioidUseServlet?setting1=ED&location=US
   Google Scholar
• Alinsky, R. H., Hadland, S. E., Matson, P. A., Cerda, M., & Saloner, B. (2020). Adolescent-serving addiction treatment facilities in the United States and the availability of medications for opioid use disorder. The Journal of Adolescent Health, 67(4), 542–549. https://doi.org/10.1016/j.jadohealth.2020.03.005
   PubMed Web of Science ®Google Scholar
• Allen, S. T., Grieb, S. M., O’Rourke, A., Yoder, R., Planchet, E., White, R. H., & Sherman, S. G. (2019). Understanding the public health consequences of suspending a rural syringe services program: A qualitative study of the experiences of people who inject drugs. Harm Reduction Journal, 16(1), 33. https://doi.org/10.1186/s12954-019-0305-7
   PubMed Web of Science ®Google Scholar
• Atkins, J., Dopp, A. L., & Temaner, E. B. (2020). Combatting the stigma of addiction-the need for a comprehensive health system approach. NAM Perspectives, 2020. https://doi.org/10.31478/202011d
   PubMedGoogle Scholar
• Baker, L. S., Smith, W., Gulley, T., & Tomann, M. M. (2020). Community perceptions of comprehensive harm reduction programs and stigma towards people who inject drugs in rural Virginia. Journal of Community Health, 45(2), 239–244. https://doi.org/10.1007/s10900-019-00732-8
   PubMed Web of Science ®Google Scholar
• Barry, C. L., McGinty, E. E., Pescosolido, B. A., & Goldman, H. H. (2014). Stigma, discrimination, treatment effectiveness, and policy: Public views about drug addiction and mental illness. Psychiatric Services (Washington, D.C.), 65(10), 1269–1272. https://doi.org/10.1176/appi.ps.201400140
   PubMed Web of Science ®Google Scholar
• Beachler, T., Zeller, T. A., Heo, M., Lanzillotta‐Rangeley, J., & Litwin, A. H. (2021). Community attitudes toward opioid use disorder and medication for opioid use disorder in a rural Appalachian county. The Journal of Rural Health, 37(1), 29–34. https://doi.org/10.1111/jrh.12503
   PubMed Web of Science ®Google Scholar
• Bielenberg, J., Swisher, G., Lembke, A., & Haug, N. A. (2021). A systematic review of stigma interventions for providers who treat patients with substance use disorders. Journal of Substance Abuse Treatment, 131, 108486. https://doi.org/10.1016/j.jsat.2021.108486
   PubMed Web of Science ®Google Scholar
• Bonnevie, E., Kaynak, O., Whipple, C. R., Kensinger, W. S., Stefanko, M., McKeon, C., Mendell, G., & Smyser, J. (2022). Life unites us: A novel approach to addressing opioid use disorder stigma. Health Education Journal, 81(3), 312–324., (), - https://doi.org/10.1177/0017896922107740924
   Web of Science ®Google Scholar
• Brown, S. A. (2011). Standardized measures for substance use stigma. Drug and Alcohol Dependence, 116(1-3), 137–141. https://doi.org/10.1016/j.drugalcdep.2010.12.005
   PubMed Web of Science ®Google Scholar
• Browne, T., Priester, M. A., Clone, S., Iachini, A., DeHart, D., & Hock, R. (2016). Barriers and facilitators to substance use treatment in the rural south: A qualitative study. The Journal of Rural Health, 32(1), 92–101. https://doi.org/10.1111/jrh.12129
   PubMed Web of Science ®Google Scholar
• Bunting, A. M., Oser, C. B., Staton, M., Eddens, K. S., & Knudsen, H. (2018). Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: A social ecological approach. Addiction Science & Clinical Practice, 13(1), 23. https://doi.org/10.1186/s13722-018-0124-2
   PubMedGoogle Scholar
• Burgess, A., Bauer, E., Gallagher, S., Karstens, B., Lavoie, L., Ahrens, K., & O’Connor, A. (2021). Experiences of stigma among individuals in recovery from opioid use disorder in a rural setting: A qualitative analysis. Journal of Substance Abuse Treatment, 130, 108488. https://doi.org/10.1016/j.jsat.2021.108488
   PubMed Web of Science ®Google Scholar
• Center for Rural Pennsylvania. (n.d.). Rural-urban maps. https://www.rural.palegislature.us/
   Google Scholar
• Centers for Disease Control and Prevention. (2021, November 17). Drug Overdose Deaths in the U.S. Top 100,000 [Press release]. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2021/20211117.htm
   Google Scholar
• Childs, E., Biello, K. B., Valente, P. K., Salhaney, P., Biancarelli, D. L., Olson, J., Earlywine, J. J., Marshall, B. D. L., & Bazzi, A. R. (2021). Implementing harm reduction in non-urban communities affected by opioids and polysubstance use: A qualitative study exploring challenges and mitigating strategies. The International Journal on Drug Policy, 90, 103080. https://doi.org/10.1016/j.drugpo.2020.103080
   PubMed Web of Science ®Google Scholar
• Chimbar, L., & Moleta, Y. (2018). Naloxone effectiveness: A systematic review. Journal of Addictions Nursing, 29(3), 167–171. https://doi.org/10.1097/JAN.0000000000000230
   PubMedGoogle Scholar
• Connery, H. S. (2015). Medication-assisted treatment of opioid use disorder: Review of the evidence and future directions. Harvard Review of Psychiatry, 23(2), 63–75. https://doi.org/10.1097/HRP.0000000000000075
   PubMed Web of Science ®Google Scholar
• Corrigan, P. W., Schomerus, G., Shuman, V., Kraus, D., Perlick, D., Harnish, A., Kulesza, M., Kane-Willis, K., Qin, S., & Smelson, D. (2017). Developing a research agenda for reducing the stigma of addictions, part II: Lessons from the mental health stigma literature. The American Journal on Addictions, 26(1), 59–66. https://doi.org/10.1111/ajad.12458
   PubMed Web of Science ®Google Scholar
• Countey, H., Steinbronn, C., & Grady, S. E. (2018). Changing student attitudes and perceptions toward opioid use disorder. The Mental Health Clinician, 8(5), 222–226. doi:https://doi.org/10.9740/mhc.2018.09.222
   PubMedGoogle Scholar
• Definitions H.B. 1393. (2022). Controlled Substance, Drug, Device and Cosmetic Act – H.B. 1393 (Session No. 2022-111). Pennsylvania General Assembly.
   Google Scholar
• Des Jarlais, D. C., McKnight, C., Goldblatt, C., & Purchase, D. (2009). Doing harm reduction better: Syringe exchange in the United States. Addiction (Abingdon, England), 104(9), 1441–1446. https://doi.org/10.1111/j.1360-0443.2008.02465.x
   PubMed Web of Science ®Google Scholar
• Evans-Lacko, S., Little, K., Meltzer, H., Rose, D., Rhydderch, D., Henderson, C., & Thornicroft, G. (2010). Development and psychometric properties of the Mental Health Knowledge Schedule. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 55(7), 440–448. https://doi.org/10.1177/070674371005500
   PubMed Web of Science ®Google Scholar
• Evans-Lacko, S., Rose, D., Little, K., Flach, C., Rhydderch, D., Henderson, C., & Thornicroft, G. (2011). Development and psychometric properties of the Reported and Intended Behaviour Scale (RIBS): A stigma-related behaviour measure. Epidemiology and Psychiatric Sciences, 20(3), 263–271. https://doi.org/10.1017/S2045796011000308
   PubMed Web of Science ®Google Scholar
• Ezell, J. M., Walters, S., Friedman, S. R., Bolinski, R., Jenkins, W. D., Schneider, J., Link, B., & Pho, M. T. (2021). Stigmatize the use, not the user? Attitudes on opioid use, drug injection, treatment, and overdose prevention in rural communities. Social Science & Medicine (1982), 268, 113470. https://doi.org/10.1016/j.socscimed.2020.113470
   PubMed Web of Science ®Google Scholar
• Frazier, W., Cochran, G., Lo-Ciganic, W. H., Gellad, W. F., Gordon, A. J., Chang, C. C. H., & Donohue, J. M. (2017). Medication-assisted treatment and opioid use before and after overdose in Pennsylvania Medicaid. JAMA, 318(8), 750–752. https://doi.org/10.1001/jama.2017.7818
   PubMed Web of Science ®Google Scholar
• Freeman, P. R., Hankosky, E. R., Lofwall, M. R., & Talbert, J. C. (2018). The changing landscape of Naloxone availability in the United States, 2011–2017. Drug and Alcohol Dependence, 191, 361–364. https://doi.org/10.1016/j.drugalcdep.2018.07.017
   PubMed Web of Science ®Google Scholar
• Grundy, S. A., Mozelewski, S. R., Adjei Boakye, E., Lee, M., & Levin, B. L. (2021). Faith leaders’ perceptions of needle exchange programs in the rural Illinois Delta Region: Religion as a social determinant of health. The American Journal on Addictions, 30(6), 560–567. https://doi.org/10.1111/ajad.13213
   PubMed Web of Science ®Google Scholar
• Hammarlund, R., Crapanzano, K. A., Luce, L., Mulligan, L., & Ward, K. M. (2018). Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug-and alcohol-use disorders. Substance Abuse and Rehabilitation, 9, 115–136. https://doi.org/10.2147/SAR.S183256
   PubMed Web of Science ®Google Scholar
• Hammer, J. H., Vogel, D. L., & Heimerdinger-Edwards, S. R. (2013). Men’s help seeking: Examination of differences across community size, education, and income. Psychology of Men & Masculinity, 14(1), 65–75. https://doi.org/10.1037/a0026813
   Web of Science ®Google Scholar
• Johnson-Kwochka, A., Aalsma, M. C., Monahan, P. O., & Salyers, M. P. (2021). Development and examination of the attribution questionnaire – Substance use disorder (AQ-SUD) to measure public stigma towards adolescents experiencing substance use disorders. Drug and Alcohol Dependence, 221, 108600. https://doi.org/10.1016/j.drugalcdep.2021.108600
   PubMed Web of Science ®Google Scholar
• Kaynak, Ö., Whipple, C. R., Bonnevie, E., Grossman, J. A., Saylor, E. M., Stefanko, M., McKeon, C., Smyser, J., & Kensinger, W. S. (2022). The Opioid Epidemic and the State of Stigma: A Pennsylvania Statewide Survey. Substance Use & Misuse, 57(7), 1120–1130. https://doi.org/10.1080/10826084.2022.206450635459425
   PubMed Web of Science ®Google Scholar
• Kennedy-Hendricks, A., Barry, C. L., Gollust, S. E., Ensminger, M. E., Chisolm, M. S., & McGinty, E. E. (2017). Social stigma toward persons with prescription opioid use disorder: Associations with public support for punitive and public health–oriented policies. Psychiatric Services (Washington, D.C.), 68(5), 462–469. https://doi.org/10.1176/appi.ps.201600056
   PubMed Web of Science ®Google Scholar
• Keyes, K. M., Cerdá, M., Brady, J. E., Havens, J. R., & Galea, S. (2014). Understanding the rural–urban differences in nonmedical prescription opioid use and abuse in the United States. American Journal of Public Health, 104(2), e52–e59. https://doi.org/10.2105/AJPH.2013.301709
   PubMed Web of Science ®Google Scholar
• Kruis, N. E., McLean, K., & Perry, P. (2021). Exploring first responders’ perceptions of medication for addiction treatment: Does stigma influence attitudes? Journal of Substance Abuse Treatment, 131, 108485. https://doi.org/10.1016/j.jsat.2021.108485
   PubMed Web of Science ®Google Scholar
• Lefebvre, C., Squiers, L., Adams, E. T., Nyblade, L., West, S., & Bann, C. (2019). Stigma and prescription opioid addiction and treatment: A national survey [Poster Presentation]. The Society of Behavioral Medicine, 40th Annual Meeting and Scientific Sessions. https://osf.io/uwhcn/?show=revision
   Google Scholar
• Link, B. G., & Phelan, J. C. (2001). Conceptualizing stigma. Annual Review of Sociology, 27(1), 363–385. https://doi.org/10.1146/annurev.soc.27.1.363
   Web of Science ®Google Scholar
• Logan, D. E., & Marlatt, G. A. (2010). Harm reduction therapy: A practice‐friendly review of research. Journal of Clinical Psychology, 66(2), 201–214. https://doi.org/10.1002/jclp.20669
   PubMed Web of Science ®Google Scholar
• Ma, J., Bao, Y. P., Wang, R. J., Su, M. F., Liu, M. X., Li, J. Q., Degenhardt, L., Farrell, M., Blow, F. C., Ilgen, M., Shi, J., & Lu, L. (2019). Effects of medication-assisted treatment on mortality among opioids users: A systematic review and meta-analysis. Molecular Psychiatry, 24(12), 1868–1883. https://doi.org/10.1038/s41380-018-0094-5
   PubMed Web of Science ®Google Scholar
• Mack, K. A., Jones, C. M., & Ballesteros, M. F. (2017). Illicit drug use, illicit drug use disorders, and drug overdose deaths in metropolitan and nonmetropolitan areas—United States. Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C.: 2002), 66(19), 1–12. http://dx.doi.org/10.15585/mmwr.ss6619a1externalicon
   PubMed Web of Science ®Google Scholar
• Madden, E. F. (2019). Intervention stigma: How medication-assisted treatment marginalizes patients and providers. Social Science & Medicine (1982), 232, 324–331. https://doi.org/10.1016/j.socscimed.2019.05.027
   PubMed Web of Science ®Google Scholar
• McGinty, E. E., & Barry, C. L. (2020). Stigma reduction to combat the addiction crisis—Developing an evidence base. The New England Journal of Medicine, 382(14), 1291–1292. https://doi.org/10.1056/NEJMp2000227
   PubMed Web of Science ®Google Scholar
• Monnat, S. M., & Rigg, K. K. (2018). The Opioid Crisis in Rural and Small Town America (National Issue Brief No. 135). The Carsey School of Public Policy at the Scholars’ Repository. Retrieved from https://scholars.unh.edu/carsey/343
   Google Scholar
• Nagin, D. S. (2005). Group-based modeling of development. Harvard University Press.
   Google Scholar
• National Harm Reduction Coalition. (2021, February 8). Syringe Access Landscape. Retrieved from https://harmreduction.org/issues/syringe-access/landscape-report/state-by-state/
   Google Scholar
• NORC. (2019). 2018 GSS cross-sectional questionnaire. Retrieved from https://gss.norc.org/Documents/quex/GSS2018%20Ballot%202%20-%20English.pdf
   Google Scholar
• Nylund-Gibson, K., & Choi, A. Y. (2018). Ten frequently asked questions about latent class analysis. Translational Issues in Psychological Science, 4(4), 440–461. https://doi.org/10.1037/tps0000176
   Google Scholar
• Oser, C. B., & Harp, K. L. (2015). Treatment outcomes for prescription drug misusers: The negative effect of geographic discordance. Journal of Substance Abuse Treatment, 48(1), 77–84. https://doi.org/10.1016/j.jsat.2014.08.002
   PubMed Web of Science ®Google Scholar
• Peiper, N. C., Clarke, S. D., Vincent, L. B., Ciccarone, D., Kral, A. H., & Zibbell, J. E. (2019). Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States. The International Journal on Drug Policy, 63, 122–128. https://doi.org/10.1016/j.drugpo.2018.08.007
   PubMed Web of Science ®Google Scholar
• Pullen, E., & Oser, C. (2014). Barriers to substance abuse treatment in rural and urban communities: Counselor perspectives. Substance Use & Misuse, 49(7), 891–901. https://doi.org/10.3109/10826084.2014.891615
   PubMed Web of Science ®Google Scholar
• Ruiz, M. S., OʼRourke, A., Allen, S. T., Holtgrave, D. R., Metzger, D., Benitez, J., Brady, K. A., Chaulk, C. P., & Wen, L. S. (2019). Using interrupted time series analysis to measure the impact of legalized syringe exchange on HIV diagnoses in Baltimore and Philadelphia. Journal of Acquired Immune Deficiency Syndromes (1999), 82(2), S148–S154. https://doi.org/10.1097/QAI.0000000000002176
   PubMedGoogle Scholar
• Schlosser, A., Habecker, P., & Bevins, R. (2022). Harm reduction in the Heartland: Public knowledge and beliefs about Naloxone in Nebraska, USA. Harm Reduction Journal, 19(1), 22. https://doi.org/10.1186/s12954-022-00606-8
   PubMed Web of Science ®Google Scholar
• Schroeder, S., Ming Tan, C., Urlacher, B., & Heitkamp, T. (2021). The role of rural and urban geography and gender in community stigma around mental illness. Health Education & Behavior, 48(1), 63–73. https://doi.org/10.1177/1090198120974963
   PubMed Web of Science ®Google Scholar
• Sexton, R. L., Carlson, R. G., Leukefeld, C. G., & Booth, B. M. (2008). Barriers to formal drug abuse treatment in the rural south: A preliminary ethnographic assessment. Journal of Psychoactive Drugs, 40(2), 121–129. https://doi.org/10.1080/02791072.2008.10400621
   PubMed Web of Science ®Google Scholar
• Sigmon, S. C. (2014). Access to treatment for opioid dependence in rural America: Challenges and future directions. JAMA Psychiatry, 71(4), 359–360. https://doi.org/10.1001/jamapsychiatry.2013.4450
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. (2022, February 15). Harm reduction. Retrieved March 4, 2022 from https://www.samhsa.gov/find-help/harm-reduction
   Google Scholar
• Taylor, S. M., & Dear, M. J. (1981). Scaling community attitudes toward the mentally ill. Schizophrenia Bulletin, 7(2), 225–240. https://doi.org/10.1093/schbul/7.2.225
   PubMed Web of Science ®Google Scholar
• Taylor, B. G., Lamuda, P. A., Flanagan, E., Watts, E., Pollack, H., & Schneider, J. (2021). Social stigma toward persons with opioid use disorder: Results from a nationally representative survey of US adults. Substance Use & Misuse, 56(12), 1752–1764. https://doi.org/10.1080/10826084.2021.1949611
   PubMed Web of Science ®Google Scholar
• Taylor, J., Ober, A. J., Kilmer, B., Caulkins, J. P., & Iguchi, M. Y. (2021). Community perspectives on supervised consumption sites: Insights from four US counties deeply affected by opioids. Journal of Substance Abuse Treatment, 131, 108397. https://doi.org/10.1016/j.jsat.2021.108397
   PubMed Web of Science ®Google Scholar
• Tempalski, B., Friedman, R., Keem, M., Cooper, H., & Friedman, S. R. (2007). NIMBY localism and national inequitable exclusion alliances: The case of syringe exchange programs in the United States. Geoforum; Journal of Physical, Human, and Regional Geosciences, 38(6), 1250–1263. https://doi.org/10.1016/j.geoforum.2007.03.012
   PubMed Web of Science ®Google Scholar
• Wakeman, S. E., & Rich, J. D. (2018). Barriers to medications for addiction treatment: How stigma kills. Substance Use & Misuse, 53(2), 330–333. https://doi.org/10.1080/10826084.2017.1363238
   PubMed Web of Science ®Google Scholar
• Whelan, A. (2022). Pennsylvania lawmakers vote to legalize fentanyl testing strips, while the fight for syringe exchanges continues. Philadelphia Inquirer. https://www.inquirer.com/health/syringe-exchange-fentanyl-testing-strips-pennsylvania-overdose-crisis-addiction-20221027.html#loaded
   Google Scholar